Default Category
-
Derivados financieros en Controladora Comercial Mexicana (CCM)
Mitchell, Jordan; Rahnema Alavi, AhmadCase F-859FinanceEl objetivo pedagógico principal del caso de Comercial Mexicana es mostrar el uso y abuso de los derivados. Comercial Mexicana, que es el tercer mayor minorista de alimentos y otros artículos de México, hizo frente a una posible quiebra en 2008 después de especular con moneda extranjera, lo que expuso a la compañía a una deuda de 1.900 millones de dólares.Starting at €8.20
-
Tale of Two Electronic Components Distributors (Spanish Version)
Raman, Ananth; Rao, Bharat P.Case HBS-604S15Service and Operations ManagementDiscute el papel de los intermediarios de distribución en la industria de componentes electrónicos, y describe las operaciones en dos de estos distribuidores. Sirve como un vehículo para discutir las funciones proporcionadas por los distribuidores en el canal. También permite a los estudiantes a entender las diferencias entre los distribuidores y discutir cómo cada uno de ellos va a hacer frente a cuestiones como la consolidación y el rápido crec...Starting at €8.20
-
Improving the Patient Experience (Spanish version)
Raman, Ananth; Tucker, AnitaCase HBS-615S02Service and Operations ManagementHealthcare has traditionally focused on medical outcomes and financial performance. The big question is always, "How much is it going to cost?" What would happen, though, if healthcare also considered the question of "How does the patient feel?" This case looks at the Cleveland Clinic's attempt to answer the latter question by attempting to institutionalize empathy as part of its delivery of care.Starting at €8.20
-
Merck: Investing in Science-Based Business (Abridged)
Raman, Ananth; Maurer, IngaCase HBS-611027-EService and Operations ManagementRay Gilmartin faces a dilemma. His company's credibility has been damaged by the recent withdrawal of Vioxx, a multi-billion dollar drug. Moreover, the withdrawal of Vioxx would imply that Merck would fail to meet analysts' earnings expectations for 2005 unless Gilmartin cuts the R&D budget. Cutting the budget might hurt morale and productivity in Merck labs.Starting at €8.20
-
Cleveland Clinic: Improving the Patient Experience
Raman, Ananth; Tucker, AnitaCase HBS-612031-EService and Operations ManagementHealthcare has traditionally focused on medical outcomes and financial performance. The big question is always, "How much is it going to cost?" What would happen, though, if healthcare also considered the question of "How does the patient feel?" This case looks at the Cleveland Clinic's attempt to answer the latter question by attempting to institutionalize empathy as part of its delivery of care.Starting at €8.20
-
Merck: Operating Science-Based Business
Raman, Ananth; Maurer, Inga; Schmidt, WilliamCase HBS-612082-EService and Operations ManagementMerck is known for its commitment to investing in basic R&D. Are Merck's long-term investments justifiable when the firm faces extreme earnings pressure?Starting at €8.20
-
México: el programa de cobertura de petróleo
Roig, Guillem; Carbonell, Oscar; Rahnema Alavi, AhmadCase F-915Economics, FinanceEl caso describe la decisión de Petróleos Mexicanos (PEMEX), la empresa petrolera estatal de México, de emplear un sistema de cobertura basado en la utilización de derivados financieros. Desde el bum del petróleo en la década de los ochenta, México se alzó como unos de los actores principales de este ámbito. Al tratarse de un sector nacionalizado, el riesgo operacional se puede propagar hasta los contribuyentes y, siendo el petróleo un activo cuy...Starting at €8.20
-
Wal-Mart's Value Creation
Krogh J.; Rahnema Alavi, AhmadCase F-769-EFinanceThis case focuses on the evaluation of Wal-Mart's outstanding growth and financial performance. The case describes the company's recent attempts to diversify into other businesses in order to maintain its remarkable growth and profitability. The case provides an excellent context for applying the Economic Added Value (EVA) model as a basis for measuring corporate financial performance. The case also explores the key benefits of EVA, and reviews t...Starting at €8.20
-
Basel II: The New Framework for Bank and Company Relations
Rahnema Alavi, Ahmad; Soley, JorgeTechnical Note FN-526-EFinanceOn June 26th, 2004, the Basel Committee on Banking Supervision published the final version of Basel II, its new capital adequacy framework for banks, which is intended to come into force in stages from the end of 2006. A key issue in shaping Basel II is the implication of the new rules concerning the access to and terms of bank credit for companies, with specific focus on small and medium size enterprises (SMEs). The objective of this technical ...Starting at €8.20
-
Basilea II: El nuevo marco de relaciones para la banca y las empresas
Rahnema Alavi, Ahmad; Soley, JorgeTechnical Note FN-526FinanceEl 26 de junio de 2004, el comité de Basilea de supervisión bancaria publicó la versión final de Basilea II, su nueva estructura de adecuación de capital para bancos, la cual estaba previsto que entrara en vigor en etapas a partir de finales de 2006. Un punto clave para Basilea II es la implicación de nuevas reglas en relación al acceso y los términos de crédito bancario para empresas, con un foco específico en empresas de pequeña y mediana enver...Starting at €8.20